- Home
- Publications
- Publication Search
- Publication Details
Title
RNAi-based therapeutics and tumor targeted delivery in cancer
Authors
Keywords
siRNA, miRNA, Non-coding RNAs, Cancer, Nanoparticles
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 182, Issue -, Pages 114113
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.addr.2022.114113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ncRNA Therapy with miRNA-22-3p- Suppresses the Growth of Triple-Negative Breast Cancer
- (2021) Aysegul Gorur et al. Molecular Therapy-Nucleic Acids
- Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer
- (2021) Mumin Alper Erdogan et al. CELLULAR SIGNALLING
- Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
- (2021) Yaacov Frishberg et al. Clinical Journal of the American Society of Nephrology
- Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy
- (2020) Yazhe Wang et al. ACS Applied Materials & Interfaces
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Regulatory Mechanism of MicroRNA Expression in Cancer
- (2020) Zainab Ali Syeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cholic acid-based mixed micelles as siRNA delivery agents for gene therapy
- (2020) Alexander J. Cunningham et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1
- (2020) Xiao Lin et al. Frontiers in Genetics
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer
- (2020) Shuangshuang Mao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma
- (2020) Teresa Fuertes et al. TRENDS IN IMMUNOLOGY
- Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
- (2020) Eleni Anastasiadou et al. CLINICAL CANCER RESEARCH
- Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy
- (2020) Goknur Kara et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma
- (2020) Yi Hou et al. Molecular Therapy-Nucleic Acids
- An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- (2019) Imane El Dika et al. ONCOLOGIST
- RNA Biology Provides New Therapeutic Targets for Human Disease
- (2019) Lorna W. Harries Frontiers in Genetics
- PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
- (2019) Zahid Hussain et al. Drug Delivery and Translational Research
- Amphipathic Chitosans Improve the Physicochemical Properties of siRNA-Chitosan Nanoparticles at Physiological Conditions
- (2019) Grazieli Olinda Martins et al. CARBOHYDRATE POLYMERS
- An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
- (2019) Mohamed F. Attia et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment
- (2019) Eda Yalcin et al. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
- (2019) Wenhua Zhang et al. International Journal of Nanomedicine
- Cationic micelle-based siRNA delivery for efficient colon cancer gene therapy
- (2019) Yongping Lu et al. Nanoscale Research Letters
- Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
- (2019) Xin Lai et al. NUCLEIC ACIDS RESEARCH
- Efficient nanocarriers of siRNA therapeutics for cancer treatment
- (2019) Md Abdus Subhan et al. Translational Research
- Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
- (2019) Hongliang He et al. ACCOUNTS OF CHEMICAL RESEARCH
- Recent advances in the targeting of systemically administered non-viral gene delivery systems
- (2019) Ikramy A. Khalil et al. Expert Opinion on Drug Delivery
- RNA therapeutics: Identification of novel targets leading to drug discovery
- (2019) Muhammad Imran Qadir et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting
- (2019) Anas Ahmad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics
- (2019) Baitang Ning et al. BIOCHEMICAL PHARMACOLOGY
- miR-155 as a novel clinical target for hematological malignancies
- (2019) Lisa Witten et al. CARCINOGENESIS
- Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
- (2019) Kenneth K.W. To et al. Expert Opinion on Drug Discovery
- Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo
- (2019) Qianqian Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNA delivery through nanoparticles
- (2019) Sharon Wei Ling Lee et al. JOURNAL OF CONTROLLED RELEASE
- Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
- (2019) Simoneide S. Titze-de-Almeida et al. Molecular Diagnosis & Therapy
- Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
- (2019) Ping-Hsiu Wu et al. Cancers
- Lipid nanocarriers for microRNA delivery
- (2019) Marcel Scheideler et al. CHEMISTRY AND PHYSICS OF LIPIDS
- A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
- (2018) Min Li et al. Acta Biomaterialia
- Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting
- (2018) Hyun Jin Kim et al. BIOMACROMOLECULES
- Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
- (2018) Chang Yu et al. BIOMATERIALS
- Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy
- (2018) Daniel F. Costa et al. BIOMEDICAL MICRODEVICES
- Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion
- (2018) Recep Bayraktar et al. CLINICAL CANCER RESEARCH
- Recent advances in siRNA delivery for cancer therapy using smart nanocarriers
- (2018) Penghui Zhang et al. DRUG DISCOVERY TODAY
- Non-viral based miR delivery and recent developments
- (2018) Annalise Elizabeth Labatut et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
- (2018) Nadda Muhamad et al. International Journal of Nanomedicine
- siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
- (2018) Yu Xia et al. International Journal of Nanomedicine
- Elongation Factor-2 Kinase (eEF-2K) Expression Is Associated with Poor Patient Survival and Promotes Proliferation, Invasion and Tumor Growth of Lung Cancer
- (2018) Ahmet Bircan et al. LUNG CANCER
- Methodologies to investigate intracellular barriers for nucleic acid delivery in non-viral gene therapy
- (2018) Lotte M.P. Vermeulen et al. Nano Today
- Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy
- (2018) Bo Zheng et al. Nanomedicine
- Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin
- (2018) Canan Schumann et al. Nanomedicine-Nanotechnology Biology and Medicine
- Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands
- (2018) Jie Tang et al. Nanoscale
- Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
- (2018) Meenakshi Malhotra et al. Oncotarget
- Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics
- (2018) Xiao Zheng et al. Theranostics
- PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy
- (2018) Jinju Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
- (2018) Anita G. Seto et al. BRITISH JOURNAL OF HAEMATOLOGY
- Abstract 504: miR-484 acts as an “oncomiR” in triple negative breast cancer cells to promote tumor growth and progression by targeting HOXA5
- (2018) Nashwa N. Kabil et al. CANCER RESEARCH
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL.
- (2018) Francine M. Foss et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo
- (2018) Xiaoli Wang et al. Drug Design Development and Therapy
- Distinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy
- (2018) Tristan D. Clemons et al. LANGMUIR
- The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
- (2018) Hamada A. Mokhlis et al. Molecular Therapy-Nucleic Acids
- Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
- (2017) Jenny G Parvani et al. ENDOCRINE-RELATED CANCER
- Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer
- (2017) Xin Luo et al. International Journal of Nanomedicine
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
- (2017) Zilan Zhou et al. Nanomedicine-Nanotechnology Biology and Medicine
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications
- (2017) Scott R. Suter et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Tumor-targeted nanomedicines for cancer theranostics
- (2017) Alexandra G. Arranja et al. PHARMACOLOGICAL RESEARCH
- Exploiting microRNAs As Cancer Therapeutics
- (2017) Tamsin Robb et al. Targeted Oncology
- Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer
- (2017) Feng-Lei Wu et al. Oncotarget
- Advances in siRNA delivery in cancer therapy
- (2017) Aishwarya Singh et al. Artificial Cells Nanomedicine and Biotechnology
- Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
- (2017) A. Cervantes et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemical and structural modifications of RNAi therapeutics
- (2016) Sook Hee Ku et al. ADVANCED DRUG DELIVERY REVIEWS
- The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
- (2016) Xinwei Cheng et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent progress in development of siRNA delivery vehicles for cancer therapy
- (2016) Hyun Jin Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
- (2016) Yuko Nakamura et al. BIOCONJUGATE CHEMISTRY
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
- (2016) Rui-Min Chang et al. CLINICAL CANCER RESEARCH
- Nanoparticle-siRNA: A potential cancer therapy?
- (2016) Samuel Wang Sherng Young et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Exploring miRNA based approaches in cancer diagnostics and therapeutics
- (2016) Shivangi Mishra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey
- (2016) Can Sarisozen et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer
- (2016) Gülay Büyükköroğlu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Progress and perspective of inorganic nanoparticle-based siRNA delivery systems
- (2016) Ying Jiang et al. Expert Opinion on Drug Delivery
- Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy
- (2016) Anish Babu et al. IEEE TRANSACTIONS ON NANOBIOSCIENCE
- Polyethyleneimine-coated quantum dots for miRNA delivery and its enhanced suppression in HepG2 cells
- (2016) Gaofeng Liang et al. International Journal of Nanomedicine
- RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy
- (2016) Venkatesh Rengaswamy et al. JOURNAL OF CONTROLLED RELEASE
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line
- (2016) Homayoon Siahmansouri et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
- (2016) Abigail Liebow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside
- (2016) Yingshan Qiu et al. MOLECULES
- Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine
- (2016) Yuran Xie et al. MOLECULES
- Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles
- (2016) Lingdan Kong et al. Nanomedicine
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
- (2016) Nazanin Hoshyar et al. Nanomedicine
- Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy
- (2016) Chong Qiu et al. Nanoscale
- Non-coding RNAs as drug targets
- (2016) Masayuki Matsui et al. NATURE REVIEWS DRUG DISCOVERY
- Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy
- (2016) Yuval Ramot et al. TOXICOLOGIC PATHOLOGY
- MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
- (2016) Recep Bayraktar et al. Oncotarget
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
- (2016) Zuhal Hamurcu et al. Oncotarget
- The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231)
- (2016) Peyman Eivazy et al. Artificial Cells Nanomedicine and Biotechnology
- A novel multifunctional biomimetic Au@BSA nanocarrier as a potential siRNA theranostic nanoplatform
- (2016) Zhiming Wang et al. Journal of Materials Chemistry B
- Multifunctional Poly(l-lactide)–Polyethylene Glycol-Grafted Graphene Quantum Dots for Intracellular MicroRNA Imaging and Combined Specific-Gene-Targeting Agents Delivery for Improved Therapeutics
- (2015) Haifeng Dong et al. ACS Applied Materials & Interfaces
- Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled Nanocarriers
- (2015) Horacio Cabral et al. ACS Nano
- Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes
- (2015) Anders E. Hansen et al. ACS Nano
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
- (2015) Huiyuan Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Preclinical and clinical development of siRNA-based therapeutics
- (2015) Gulnihal Ozcan et al. ADVANCED DRUG DELIVERY REVIEWS
- MicroRNA (miRNA) in cancer
- (2015) Kaladhar B Reddy Cancer Cell International
- Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment
- (2015) N. Vijayakameswara Rao et al. Expert Opinion on Drug Delivery
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Single-walled carbon nanotubes functionalized with aptamer and piperazine–polyethylenimine derivative for targeted siRNA delivery into breast cancer cells
- (2015) Marzieh Mohammadi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Control of polymeric nanoparticle size to improve therapeutic delivery
- (2015) John W. Hickey et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic potential of inhibiting ABCE1 and eRF3 genes via siRNA strategy using chitosan nanoparticles in breast cancer cells
- (2015) Bagdat Burcu Cengiz et al. JOURNAL OF NANOPARTICLE RESEARCH
- Targeting c-MYC in Platinum-Resistant Ovarian Cancer
- (2015) J. M. Reyes-Gonzalez et al. MOLECULAR CANCER THERAPEUTICS
- Micelle-like Nanoparticles as Carriers for DNA and siRNA
- (2015) Gemma Navarro et al. MOLECULAR PHARMACEUTICS
- 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
- (2015) João Conde et al. Nano Today
- Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect
- (2015) Elizabeth Huynh et al. Nanomedicine
- Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer
- (2015) Xiaoxuan Liu et al. Nanoscale
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer nanomedicine: from targeted delivery to combination therapy
- (2015) Xiaoyang Xu et al. TRENDS IN MOLECULAR MEDICINE
- Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy
- (2015) Sanchaika Gaur et al. Oncotarget
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
- (2015) Amy Chan et al. Molecular Therapy-Nucleic Acids
- Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
- (2014) Edward A. Sykes et al. ACS Nano
- Liposomal siRNA nanocarriers for cancer therapy
- (2014) Bulent Ozpolat et al. ADVANCED DRUG DELIVERY REVIEWS
- Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs
- (2014) Lin Zhu et al. BIOMATERIALS
- Nanomaterials for Theranostics: Recent Advances and Future Challenges
- (2014) Eun-Kyung Lim et al. CHEMICAL REVIEWS
- miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
- (2014) Volker Baumann et al. Future Medicinal Chemistry
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors
- (2014) S Essex et al. GENE THERAPY
- Non-viral nanocarriers for siRNA delivery in breast cancer
- (2014) Jing Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
- (2014) C. L. Daige et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
- (2014) C. V. Pecot et al. MOLECULAR CANCER THERAPEUTICS
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine
- (2014) Hui Yi Xue et al. Nanomedicine
- A promoter-level mammalian expression atlas
- (2014) NATURE
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas
- (2014) D. Schramek et al. SCIENCE
- Tumor-Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy
- (2014) Sook Hee Ku et al. Advanced Healthcare Materials
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
- (2013) G. Reid et al. ANNALS OF ONCOLOGY
- A review of the current status of siRNA nanomedicines in the treatment of cancer
- (2013) Pauline Resnier et al. BIOMATERIALS
- Systematic classification of non-coding RNAs by epigenomic similarity
- (2013) Mikhail G Dozmorov et al. BMC BIOINFORMATICS
- Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia
- (2013) X. Huang et al. CLINICAL CANCER RESEARCH
- Chitosan-based siRNA delivery systems
- (2013) Héloïse Ragelle et al. JOURNAL OF CONTROLLED RELEASE
- Lipid-based nanoparticles in the systemic delivery of siRNA
- (2013) Qiaoya Lin et al. Nanomedicine
- RNAi screens in mice identify physiological regulators of oncogenic growth
- (2013) Slobodan Beronja et al. NATURE
- First microRNA mimic enters clinic
- (2013) Aaron Bouchie NATURE BIOTECHNOLOGY
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutant KRAS is a druggable target for pancreatic cancer
- (2013) E. Zorde Khvalevsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
- (2013) Ibrahim Tekedereli et al. Molecular Therapy-Nucleic Acids
- Lipid nanoparticle delivery systems for siRNA-based therapeutics
- (2013) C. Wan et al. Drug Delivery and Translational Research
- The Effect of Nanoparticle Polyethylene Glycol Surface Density on Ligand-Directed Tumor Targeting Studied in Vivo by Dual Modality Imaging
- (2012) Sjoerd Hak et al. ACS Nano
- Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
- (2012) Xue-Qing Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
- (2012) Alexandre Albanese et al. Annual Review of Biomedical Engineering
- Delivering the promise of miRNA cancer therapeutics
- (2012) Diane M. Pereira et al. DRUG DISCOVERY TODAY
- AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
- (2012) Joerg Engel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Virus-mediated gene delivery for human gene therapy
- (2012) Mauro Giacca et al. JOURNAL OF CONTROLLED RELEASE
- Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
- (2012) Diana Guzman-Villanueva et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
- (2012) Ibrahim Tekedereli et al. PLoS One
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Recent advances of siRNA delivery by nanoparticles
- (2011) Xudong Yuan et al. Expert Opinion on Drug Delivery
- Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
- (2011) Dirk Strumberg et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models
- (2010) A. Santel et al. CLINICAL CANCER RESEARCH
- Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
- (2010) Jianqiu Wang et al. CURRENT DRUG METABOLISM
- Liposomal cancer therapy: exploiting tumor characteristics
- (2010) Thomas Kaasgaard et al. Expert Opinion on Drug Delivery
- Efficient and targeted delivery of siRNA in vivo
- (2010) Min Suk Shim et al. FEBS Journal
- The role of HER2 in cancer therapy and targeted drug delivery
- (2010) Wanyi Tai et al. JOURNAL OF CONTROLLED RELEASE
- The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
- (2010) Ngoc Trinh Huynh et al. Nanomedicine
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
- (2010) Li Ma et al. NATURE CELL BIOLOGY
- Delivery of RNAi mediators
- (2010) Lance P. Ford et al. Wiley Interdisciplinary Reviews-RNA
- Lipidic Systems for In Vivo siRNA Delivery
- (2009) Sherry Y. Wu et al. AAPS Journal
- Nanomedicine based approaches for the delivery of siRNA in cancer
- (2009) B. Ozpolat et al. JOURNAL OF INTERNAL MEDICINE
- Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
- (2009) R. Juliano et al. MOLECULAR PHARMACEUTICS
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- On the road to reading the RNA-interference code
- (2009) Haruhiko Siomi et al. NATURE
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
- Peptide- and polymer-based delivery of therapeutic RNA
- (2009) Thomas Fröhlich et al. Soft Matter
- Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
- (2008) M. Aleku et al. CANCER RESEARCH
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor
- (2008) Virginia M. Platt et al. MOLECULAR PHARMACEUTICS
- Central Delivery of Dicer-substrate siRNA: A Direct Application for Pain Research
- (2008) Louis Doré-Savard et al. MOLECULAR THERAPY
- PSA fluoroimmunoassays using anti-PSA ScFv and quantum-dot conjugates
- (2008) Yunjun Wang et al. Nanomedicine
- Nanoparticle-mediated cellular response is size-dependent
- (2008) Wen Jiang et al. Nature Nanotechnology
- Nanoparticles for drug delivery in cancer treatment
- (2008) Barbara Haley et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles
- (2007) Derek W. Bartlett et al. BIOTECHNOLOGY AND BIOENGINEERING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search